Literature DB >> 34020666

Publisher Correction to: Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole.

.   

Abstract

Entities:  

Year:  2021        PMID： 34020666      PMCID： PMC8139027          DOI： 10.1186/s12967-021-02875-6

Source DB:  PubMed          Journal:  J Transl Med        ISSN： 1479-5876            Impact factor:   5.531


× No keyword cloud information.
  1 in total

1.  Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole.

Authors:  L D Crosby; S Kalanidhi; A Bonilla; A Subramanian; J S Ballon; H Bonilla
Journal:  J Transl Med       Date:  2021-02-03       Impact factor: 5.531
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.